Yahoo Web Search

Search results

1. • Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by StockNews.com to “Strong-Buy”

     ETF DAILY NEWS· 1 day ago

     JPMorgan Chase & Co. boosted their target price on Vertex Pharmaceuticals from $390.00 to $438.00 and gave the stock an overweight rating ...

2. • Evercore ISI’s latest rating for VRTX stock – Knox Daily

     Knox Daily· 1 day ago

     [NASDAQ:VRTX] saw its stock jump 1.04% to $445.21. Over the last five days, the stock has gained 5.31%. Vertex Pharmaceuticals ...

3. • Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Compre

     Guru Focus· 7 days ago

     With an Earnings Per Share (EPS) of 15.41, the question arises: is Vertex Pharmaceuticals currently overvalued? This analysis aims to explore the intrinsic ...

4. • 

     Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock

     Zacks via Yahoo Finance· 7 days ago

     Why This 1 Growth Stock Should Be On Your Watchlist For growth investors, a company's financial...

5. • 

     Vertex Stock Hit All-Time High, Paused, Rising Again

     Investor's Business Daily· 7 days ago

     Highly rated Vertex Pharmaceuticals (VRTX) continues to trade near its all-time high. The upgraded Relative Strength Rating shows that Vertex stock ...

6. • Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Vertex Pharmaceuticals...

     Benzinga· 6 days ago

     Loading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals . Looking at options history ...

7. • 

     Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating

     Investor's Business Daily· 7 days ago

     Over 100 years of market history reveals that the stocks that go on to make the biggest gains tend...

8. • 

     Is CRISPR Therapeutics Stock a Buy?

     Motley Fool via Yahoo Finance· 4 days ago

     These procedures must be performed in authorized treatment centers. CRISPR Therapeutics originally created Casgevy, but co-markets it with the much...

9. • 

     Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.

     Motley Fool via Yahoo Finance· 6 days ago

     Is CRISPR stock a buy? CRISPR remains on track to start clinical trials for CTX112, a gene-editing...

10. • 

      2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential

      Motley Fool via Yahoo Finance· 7 days ago

      The company is one of the leaders in gene therapy. It is developing several products...for the...